The Mediterranean Neuroscience Society Conference 2023Neurological disorders such as multiple sclerosis, chronic pain, fibromyalgia, migraine, epilepsy, and stress and anxiety-related disorders pose significant challenges to individuals and healthcare systems worldwide.
Existing therapies do not meet the diverse needs of all patients and often come with their own set of limitations. Therefore, it is crucial to continue exploring innovative and personalized treatment options to address these complex conditions.
This proposal aims to explore the therapeutic and clinical management strategies focusing on novel approaches to neurological disease therapy, the neuroprotective role of bioactive compounds, and the identification of biomarkers of vulnerability. There are currently no effective treatments for these neurological diseases. Innovative therapeutic approaches are therefore needed. Also identifying biomarkers of vulnerability is crucial for early diagnosis, targeted therapy, and disease prognosis.
This collection will gather manuscripts exploring the emerging field of precision medicine, where natural and unnatural compounds are being investigated for their potential neuroprotective and therapeutic effects. Cutting-edge research exploring among all, the identification of specific molecular targets and the development of personalized treatment regimens for patients will be considered for paper submission.
This collection will thus focus on the exploration of biomarkers that can indicate susceptibility to conditions such as neurodegenerative diseases, neuro-inflammatory conditions, chronic pain, fibromyalgia, migraine, epilepsy, stress and anxiety-related disorders. We will discuss the latest research on both genetic and non-genetic biomarkers and their potential utility in clinical practice.
The Mediterranean Neuroscience Society Conference 2023Neurological disorders such as multiple sclerosis, chronic pain, fibromyalgia, migraine, epilepsy, and stress and anxiety-related disorders pose significant challenges to individuals and healthcare systems worldwide.
Existing therapies do not meet the diverse needs of all patients and often come with their own set of limitations. Therefore, it is crucial to continue exploring innovative and personalized treatment options to address these complex conditions.
This proposal aims to explore the therapeutic and clinical management strategies focusing on novel approaches to neurological disease therapy, the neuroprotective role of bioactive compounds, and the identification of biomarkers of vulnerability. There are currently no effective treatments for these neurological diseases. Innovative therapeutic approaches are therefore needed. Also identifying biomarkers of vulnerability is crucial for early diagnosis, targeted therapy, and disease prognosis.
This collection will gather manuscripts exploring the emerging field of precision medicine, where natural and unnatural compounds are being investigated for their potential neuroprotective and therapeutic effects. Cutting-edge research exploring among all, the identification of specific molecular targets and the development of personalized treatment regimens for patients will be considered for paper submission.
This collection will thus focus on the exploration of biomarkers that can indicate susceptibility to conditions such as neurodegenerative diseases, neuro-inflammatory conditions, chronic pain, fibromyalgia, migraine, epilepsy, stress and anxiety-related disorders. We will discuss the latest research on both genetic and non-genetic biomarkers and their potential utility in clinical practice.